Duke University Health System (DUHS)

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Multiple myeloma2 trials
• Acute myeloid leukaemia1 trial

Phase

• Phase 11 trial
• Phase 1/21 trial
• Phase 31 trial

Status

• Active, not recruiting1 trial
• Recruiting1 trial
• Terminated1 trial

Lead sponsor

• Caribou Biosciences, Inc.1 trial
• GlycoMimetics Incorporated1 trial
• Regeneron Pharmaceuticals1 trial

Running trials

• Active, not recruiting

  A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment

  NCT05828511· Phase 1/2· Regeneron Pharmaceuticals· Source

• Recruiting

  CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma

  NCT05722418· Phase 1· Caribou Biosciences, Inc.· Source

  Contact: Matthew Fisher

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Multiple myeloma1 recruiting

Closed trials

• Terminated

  Study to Determine the Efficacy of Uproleselan (GMI-1271) in Combination With Chemotherapy to Treat Relapsed/Refractory Acute Myeloid Leukemia

  NCT03616470· Phase 3· GlycoMimetics Incorporated· Source